SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000217028-01-500004
Filing Date
2001-04-26
Accepted
2001-04-26 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 INTROGEN 13G 2001 introgen13g.txt SC 13G 8061
  Complete submission text file 0000217028-01-500004.txt   10142
Mailing Address
Business Address 500 ARCOLA RD P O BOX 1200 M/S 5B14 COLLEGEVILLE PA 19426-0107 6104548000
RHONE POULENC RORER INC (Filed by) CIK: 0000217028 (see all company filings)

IRS No.: 231699163 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Subject) CIK: 0001018710 (see all company filings)

IRS No.: 742704230 | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-61001 | Film No.: 1611771
SIC: 2834 Pharmaceutical Preparations